Robert Coffin, President & Chief R&D Officer at Replimune Group, Inc. (REPL), sold 220,000 shares at $40.04 ($8.8M) on 2020-12-22, disclosed to the SEC on 2020-12-28.
Open-market sale of $8.8M REPL by President & Chief R&D Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REPL | SELL | 2022-05-18 | $167K | — | Filing → |
| REPL | SELL | 2021-07-07 | $625K | — | Filing → |
| REPL | SELL | 2021-06-30 | $3.0M | — | Filing → |